x

Posted 28 February, 2024

IR-Med, Inc. appointed new CEO

CEO Change detected for ticker OTC:IRME in a 8-K filed on 28 February, 2024.


  On February 22, 2024, the board of directors (the "Board") of IR-Med, Inc. (the "Company") terminated the employment of Tzur Di-Cori pursuant to which he ceased serving as the Company's Chief Executive Officer, effective immediately.  

Don't how to trade CEO change? Read Reasons for CEO Turnover and Effect on Stock Performance.
Overview of IR-Med, Inc.
Health Care/Life Sciences • Medical Equipment/Supplies
IR-Med, Inc. is engaged in the designing and developing devices utilizing spectrographic usability medical devices based on the combination of Infra-Red (IR) and Artificial Intelligence (AI) technologies. The company was founded by Ronnie Klein and Yaniv Cohen in April 2007 and is headquartered in Rosh Haayin, Israel.
Market Cap
$101M
View Company Details
IR-Med, Inc. by TradingView
Relevant filing section
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. 


On February 22, 2024, the board of directors (the "Board") of IR-Med, Inc. (the "Company") terminated the employment of Tzur Di-Cori pursuant to which he ceased serving as the Company's Chief Executive Officer, effective immediately. The termination of Mr. Di-Cori was not related to any disagreement with the Company on any matter relating to the Company's operations, policies or practices.